19 June 2020 - Deborah Wilkes
Premium
AFT Pharmaceuticals, owner of the Maxigesic combination painkiller, has raised around NZD10 million (USD6.47 million) through issuing new shares. The New Zealand-based company said the move would “increase liquidity and reduce debt”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.